Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARD | Q03181 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27023 | 0.87 | — | — | |
| SCHEMBL4816014 | 0.87 | LMNA (0.50) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Acetic Acid SCHEMBL30401693 | 0.84 | CTH (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Acetic Acid SCHEMBL31437203 | 0.84 | CTH (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL667660 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Ammonia Solution, Strong SCHEMBL7262621 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL9393647 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Water SCHEMBL9703549 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL4015593 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Ammonia Solution, Strong SCHEMBL7262619 | 0.83 | LMNA (0.47) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112080560-B | Use of CD177 for the preparation of a product for diagnosing biliary tract occlusion | 广州市妇女儿童医疗中心（广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心） | 2024-01-26 | — | — | CN | disclosed |
| CN-117288962-A | Application of reagent for detecting marker combination in preparation of biliary tract locking diagnosis product | 广州市妇女儿童医疗中心 | 2023-12-26 | — | — | CN | disclosed |
| EP-2729664-B1 | SAMPLING PROCEDURE FOR POLYMER-BASED SOLUTIONS USED IN UNDERGROUND FORMATIONS | SNF GROUP (FR) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022045240-A1 | SEALING AGENT FOR LIQUID CRYSTAL DISPLAY ELEMENT, VERTICAL CONDUCTION MATERIAL, AND LIQUID CRYSTAL DISPLAY ELEMENT | 積水化学工業株式会社 | 2022-03-03 | — | — | WO | disclosed |
| US-10364262-B2 | Method for the synthesis of N-phosphonomethyliminodiacetic acid | MONSANTO TECHNOLOGY LLC (US) | 2019-07-30 | — | — | US | disclosed |
| CN-104854117-B | Process for the synthesis of N-phosphonomethyliminodiacetic acid | 孟山都技术有限责任公司 | 2018-12-25 | — | — | CN | disclosed |
| CN-103649462-B | The sampling method of polymer-based solution for subterranean strata | S.P.C.M.股份公司 | 2018-08-07 | — | — | CN | disclosed |
| US-9714889-B2 | Sampling procedure for polymer-based solutions used in underground formations | S.P.C.M. SA (FR) | 2017-07-25 | — | — | US | disclosed |
| EP-2563122-B1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2016-06-08 | — | — | EP | disclosed |
| CN-102428157-B | The water-soluble polymers of single mixed thing and the new formulation of stabilization additives that chemistry improves oil recovery injection fluid is can be used for for injecting | S.P.C.M. S.A. (FR) | 2015-09-09 | — | — | CN | disclosed |
| US-9040518-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2015-05-26 | — | — | US | disclosed |
| US-20140134749-A1 | SAMPLING PROCEDURE FOR POLYMER-BASED SOLUTIONS USED IN UNDERGROUND FORMATIONS | S.P.C.M. SA (FR) | 2014-05-15 | — | — | US | disclosed |
| EP-2729664-A1 | SAMPLING PROCEDURE FOR POLYMER-BASED SOLUTIONS USED IN UNDERGROUND FORMATIONS | S.P.C.M. SA (FR) | 2014-05-14 | — | — | EP | disclosed |
| CN-103649462-A | Sampling procedure for polymer-based solutions used in underground formations | SPCM SA | 2014-03-19 | — | — | CN | disclosed |
| WO-2014012986-A1 | METHOD FOR THE SYNTHESIS OF N-PHOSPHONOMETHYLIMINODIACETIC ACID | STRAITMARK HOLDING AG (CH) | 2014-01-23 | — | — | WO | disclosed |
| EP-2563122-A1 | CHEMICAL COMPOUNDS | Glaxosmithkline LLC (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20130029938-A1 | Chemical Compounds | GLAXOSMITHKLINE LLC (US) | 2013-01-31 | — | — | US | disclosed |
| WO-2013004650-A1 | SAMPLING PROCEDURE FOR POLYMER-BASED SOLUTIONS USED IN UNDERGROUND FORMATIONS | S.P.C.M. SA (FR) | 2013-01-10 | — | — | WO | disclosed |
| CN-102428157-A | Novel formulation of water-soluble polymers and stabilizing additives for injection of a single compound useful as injection fluid for chemical enhanced oil recovery | SPCM SA | 2012-04-25 | — | — | CN | disclosed |
| WO-2011137135-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029938-A1 | Chemical Compounds | CYP11B1, GOT2, CYP11B2 | FFAR3 644/4885HDAC3 806/4885HDAC1 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.